Rosen Law Firm reminds purchasers of Phreesia common stock between May 8, 2025 and March 30, 2026 of the July 13, 2026 lead plaintiff deadline in a securities class action. If you purchased Phreesia common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The lawsuit alleges that defendants made false or misleading statements and concealed material adverse facts about Phreesia's slowing demand and reduced visibility in key revenue streams, notably weakened pharmaceutical marketing commitments in its Network Solutions segment. Investors who wish to serve as lead plaintiff must move the Court no later than July 13, 2026.
Phreesia IncSecurities class action lawsuit alleges false statements about slowing demand and reduced visibility in key revenue streams.